glp 1 meds and dementia GLP-1 Drug Fails to Quell Alzheimer's in Novo Nordisk Trials GLP-1 drugs failed to slow

Cell Metab (2018) 27(4):786804.10.1016/j.cmet.2018.02.008 84 ShinACamilleriMBusciglioIBurtonDStonerENoonanPet alRandomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics

A PubMed scoping review of high-dose IV vitamin C found over 932 adverse events across 2,801 participants, including kidney damage from oxalate buildup and red blood cell breakdown in G6PD-deficient patients

ACN ice-cold acetonitrile Stability half-lives were determined assuming a normal single phase exponential decay using Prism 5 graphical/statistical program (GraphPad, San Diego, CA)

The injection produces no metabolic effect, and they've wasted both the peptide and the injection cycle